Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02990793 · ClinicalTrials.gov registry record · NA

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

A NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder, sponsored by Wave Neuroscience.

Completed
Registry status
NA
Development phase
158
Enrollment target
8
Study locations

NCT02990793 is a NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder that has completed, run by Wave Neuroscience. The registered enrollment target is 158 participants, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (43% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02990793, a NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder, has completed, sponsored by Wave Neuroscience.

COMPLETED
Registry status
NA
Development phase
158 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder

Conditions Studied

Traumatic Brain Injury Posttraumatic Stress Disorder Postconcussive Symptoms

Interventions

  • DEVICE Active MeRT Treatment
  • DEVICE Sham MeRT Treatment

Study Locations (8)

California

  • BrainHealth Solutions - Costa Mesa
  • VA Long Beach Healthcare System - Long Beach
  • SoCal Neuroscience Research Unit - San Diego

North Carolina

  • UNC Rex Hospital - Raleigh

Ohio

  • Columbus Brain Research Center - Columbus

Pennsylvania

  • Center for Interventional Pain and Spine - Bryn Mawr

Texas

  • Texas A&M Research Center - Plano

Washington

  • Seattle Neuropsychiatric Treatment Center (Seattle NTC) - Bellevue

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2022-04-04
Est. Completion 2025-11-04
Phase NA

Sponsor

Wave Neuroscience

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02990793

The ClinicalTrials.gov registry entry for NCT02990793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (43% lower). The listed sponsor is Wave Neuroscience, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Active MeRT Treatment is the first listed.

NCT02990793 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT02990793 about?

NCT02990793 is a clinical study titled "Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder". The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder

What is the current status of trial NCT02990793?

This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2022-04-04. Estimated completion is 2025-11-04.

What conditions does trial NCT02990793 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Posttraumatic Stress Disorder, Postconcussive Symptoms.

What interventions are being tested in trial NCT02990793?

The interventions under investigation include: Active MeRT Treatment (DEVICE), Sham MeRT Treatment (DEVICE).

Who is sponsoring clinical trial NCT02990793?

This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02990793 being conducted?

This trial has 8 study locations across California, North Carolina, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Brain Injury

All registered trials for this condition

Posttraumatic Stress Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.